Furunculosis in Salmonids: Detection and Prevention

1. Introduction

Furunculosis is a systemic bacterial disease affecting salmonid fish species, caused by the Gram-negative bacterium Aeromonas salmonicida subsp. salmonicida. The disease has been recognized in aquaculture since the late 19th century and remains one of the most economically significant bacterial infections in salmonid farming operations worldwide [1, 2]. Outbreaks result in high morbidity and mortality, particularly in Atlantic salmon (Salmo salar), rainbow trout (Oncorhynchus mykiss), and brown trout (Salmo trutta) [3]. The pathogen exhibits a strong tropism for lymphoid and renal tissues, leading to septicemia and characteristic furuncular lesions [4]. This article provides a detailed examination of the pathogen, clinical presentations, diagnostic methodologies, and prevention strategies, with a focus on molecular detection and vaccine-mediated immunoprophylaxis.

2. Etiology and Pathogenesis

Aeromonas salmonicida is a non-motile, facultatively anaerobic, rod-shaped bacterium within the family Aeromonadaceae [5]. The bacterium produces a polysaccharide surface layer (A-layer) composed of a crystalline array of surface proteins that mediates adherence, serum resistance, and macrophage evasion [6]. Key virulence factors include a type III secretion system (T3SS) that injects effector proteins into host cells, causing cytoskeletal disruption and apoptosis [7], as well as secreted proteases (e.g., serine protease and metalloprotease) that degrade host tissues and facilitate systemic dissemination [8].

The bacterium gains entry through the gills, skin abrasions, or gastrointestinal epithelium [9]. Following adhesion, it multiplies in the bloodstream and colonizes the spleen, kidney, and liver. The hallmark lesion, a furuncle, forms when bacterial aggregates and host inflammatory cells create liquefactive necrosis in skeletal muscle and subcutaneous tissues [10]. Atypical strains such as A. salmonicida subsp. achromogenes cause ulcerative disease with less pronounced furuncle formation [11].

3. Clinical Signs and Pathology

3.1 Acute Furunculosis

Acute outbreaks present with sudden mortality, often without external signs. Affected fish exhibit lethargy, anorexia, darkening of the skin, and exophthalmia [12]. Postmortem findings include splenomegaly, renomegaly, petechial hemorrhages on the liver and peritoneum, and congested gills [13]. Histologically, there is multifocal necrosis in the hematopoietic tissues of the kidney and spleen.

3.2 Subacute and Chronic Furunculosis

In subacute cases, one or more furuncles appear on the flank or dorsal musculature. These lesions are raised, fluid-filled swellings that rupture, releasing a serosanguinous exudate [14]. Chronic infections manifest as persistent low-level mortality, reduced growth rates, and lateral muscle erosion [15]. Carrier fish may harbor the bacterium in the kidney and intestinal tract without overt signs [16].

4. Diagnostic Approaches

Accurate diagnosis is essential for disease management and verification of freedom from infection in broodstock and smolts. Diagnostic methods include direct examination, culture, serology, and molecular assays.

4.1 Direct Examination

Wet mounts of furuncle fluid or kidney tissue can reveal highly motile, non-flagellated rods when viewed under phase-contrast microscopy. Gram staining shows Gram-negative rods [17]. However, direct detection is insufficient for speciation.

4.2 Bacterial Culture

A. salmonicida grows on tryptone soya agar (TSA) and brain heart infusion (BHI) agar supplemented with cofactors. Colonies appear as smooth, creamy, non-pigmented to pale brown after 24 to 48 hours at 22 C [18]. The bacterium produces a brown, water-soluble pigment on tyrosine-containing media, a diagnostic feature [19]. Selective media such as Coomassie Brilliant Blue agar (CBB agar) enhance detection by binding the A-layer [20]. Table 1 summarizes key cultural characteristics.

Table 1. Key Cultural Characteristics of Aeromonas salmonicida subsp. salmonicida.

4.3 Biochemical Identification

Commercial identification strips (e.g., API 20E system) can differentiate A. salmonicida from other Aeromonas species [21]. Key biochemical markers include inability to produce indole, lack of motility, and absence of growth at 37 C [22].

4.4 Serological Detection

Monoclonal antibodies against the A-layer protein (VapA) enable rapid detection via agglutination tests or enzyme-linked immunosorbent assays (ELISAs) [23]. The ELISA for A. salmonicida antigen shares conceptual similarities with the Enzyme-Linked Immunosorbent Assay (ELISA) for Feline Leukemia Virus. Direct ELISA can detect bacterial antigen in kidney and spleen homogenates with a sensitivity of approximately 10^4 CFU/g tissue [24].

4.5 Molecular Diagnostics

Polymerase chain reaction (PCR) has become the gold standard for sensitive and specific detection of A. salmonicida [25]. Target genes include the surface A-layer gene vapA, the glycerophospholipid-cholesterol acyltransferase gene gcat, and the 16S rRNA gene [26, 27]. Real-time quantitative PCR (qPCR) assays allow quantitation of bacterial load and differentiation of carrier states [28]. A multiplex PCR can simultaneously distinguish typical and atypical subspecies [29].

4.5.1 Conventional PCR Protocol

Standard PCR uses primers targeting vapA (forward AERO1, reverse AERO2) generating a 421 bp amplicon [30]. Cycling conditions: initial denaturation 95 C for 5 minutes; 35 cycles of 95 C for 30 seconds, 55 C for 30 seconds, 72 C for 30 seconds; final extension 72 C for 5 minutes. Products are resolved on 1.5% agarose gels [31].

4.5.2 Loop-Mediated Isothermal Amplification (LAMP)

LAMP assays targeting the gcat gene allow field-based detection without thermocyclers. The reaction runs at 65 C for 60 minutes, and positive results are visualized by color change using a fluorescent dye [32]. LAMP sensitivity is comparable to PCR, with a detection limit of 10^2 CFU per reaction [33].

4.5.3 Whole-Genome Sequencing

Next-generation sequencing approaches have been applied for epidemiological typing of A. salmonicida outbreaks [34]. Core genome multilocus sequence typing (cgMLST) differentiates clonal lineages and identifies antimicrobial resistance determinants [35].

5. Diagnostic Decision Workflow

The following Mermaid diagram illustrates a diagnostic algorithm for furunculosis.

flowchart TD
    A[Fish with clinical signs: lethargy, furuncles, mortality], > B[Clinical and gross pathology examination]
    B, > C[Collect kidney, spleen, furuncle fluid samples]
    C, > D{Direct microscopy}
    D, >|Gram-negative rods| E[Inoculate TSA and CBB agar; incubate 22°C, 48h]
    D, >|No visible bacteria| E
    E, > F[Colony morphology & pigment?]
    F, >|Brown pigment on tyrosine agar| G[Biochemical identification (API 20E)]
    F, >|No pigment| H[PCR for vapA and gcat]
    G, > I[Confirm as A. salmonicida]
    H, > I
    I, > J[Antimicrobial susceptibility test]
    I, > K[Report to farm management]

6. Prevention Strategies

6.1 Biosecurity in Aquaculture

Biosecurity measures are critical to preventing furunculosis outbreaks. Recommended practices include:

• Use of disinfected eggs from certified disease-free broodstock [36].
• Quarantine of new fish introductions for a minimum of 4 weeks with screening by PCR [37].
• Single-year-class rearing to reduce vertical transmission [38].
• Disinfection of nets, tanks, and equipment with Virkon or chlorine-based agents at appropriate contact times [39].
• Reduction of environmental stressors: temperature fluctuations, high stocking densities, and low dissolved oxygen [40].

6.2 Vaccination

Vaccination has been the mainstay of furunculosis control in commercial salmonid aquaculture [41]. Both killed whole-cell bacterins and recombinant antigen vaccines are available. The A-layer protein (VapA) and T3SS components are primary immunogens [42].

6.2.1 Whole-Cell Bacterins

Formalin-killed A. salmonicida vaccines are administered via intraperitoneal (IP) injection or immersion. IP vaccines confer strong systemic immunity with protection lasting up to the harvest stage [43]. Adjuvant oils (e.g., Freund's incomplete adjuvant) are often included to enhance duration of immunity [44].

6.2.2 Recombinant and Subunit Vaccines

Recombinant VapA expressed in Escherichia coli induces a protective antibody response in Atlantic salmon [45]. DNA vaccines encoding the vapA gene have been tested but have not reached widespread field application due to regulatory hurdles [46].

6.2.3 Autogenous Vaccines

For farms with recurring outbreaks caused by a specific local strain, autogenous vaccines can be produced from the isolated pathogen under veterinary prescription [47].

6.3 Chemotherapy and Antimicrobial Stewardship

Antibiotics such as oxolinic acid, florfenicol, and oxytetracycline have been used for therapeutic intervention during outbreaks [48]. However, antimicrobial resistance in A. salmonicida is an increasing concern, particularly to oxytetracycline and quinolones [49]. Therefore, antimicrobial susceptibility testing by disk diffusion or broth microdilution is recommended before treatment [50].

7. Comparative Perspective: Resistance and Surveillance

The emergence of antimicrobial resistance in A. salmonicida parallels trends observed in other aquatic bacterial pathogens. For example, detection of resistance genes via PCR is routine in diagnostic laboratories. The parallels between furunculosis and other bacterial diseases of fish, such as Streptococcus iniae and Lactococcus garvieae Infections in Farmed Fish: Detection and Antimicrobial Stewardship, underscore the need for integrated disease management programs.

Similarly, the application of molecular diagnostic platforms (e.g., multiplex PCR) is comparable to the approaches used for Avian Pathogenic Escherichia coli (APEC) in Broilers: Virulence Genes, Serotyping, and Vaccine Development. Such cross-species diagnostic strategies highlight the utility of robust molecular target selection.

8. Conclusions

Furunculosis remains a leading infectious threat in salmonid aquaculture. Accurate diagnosis relies on a combination of culture, serology, and molecular assays, with PCR providing superior sensitivity and speed. Prevention through biosecurity and vaccination is the most effective control strategy. Ongoing genomic surveillance is necessary to monitor the emergence of antimicrobial resistance and vaccine escape variants. Continued research into recombinant and DNA-based vaccines may offer improved protection against this persistent pathogen.

References

[1] MacMillan, J. R. (1981). Furunculosis of salmonids. Journal of Fish Diseases, 4(4), 295-310.

[2] Bernoth, E. M., & Hine, P. M. (1991). Furunculosis in fish: a review. Veterinary Research Communications, 15(6), 449-467.

[3] Austin, B., & Austin, D. A. (2016). Bacterial Fish Pathogens: Disease of Farmed and Wild Fish. 6th ed. Springer.

[4] Cipriano, R. C. (2001). Aeromonas salmonicida: an overview. Fish Pathology, 36(3), 117-129.

[5] Colquhoun, D. J., & Sørum, H. (2001). Temperature dependent siderophore production in Aeromonas salmonicida. FEMS Microbiology Letters, 202(2), 207-211.

[6] Udey, L. R., & Fryer, J. L. (1978). Immunization of fish with bacterins of Aeromonas salmonicida. Marine Fisheries Review, 40(3), 12-17.

[7] Burr, S. E., Stuber, K., & Frey, J. (2003). The type III secretion system of Aeromonas salmonicida subsp. salmonicida is required for virulence. Molecular Microbiology, 47(5), 1403-1418.

[8] Sakai, D. K. (1985). Pathogenicity of Aeromonas salmonicida: a review. Fish Pathology, 20(2-3), 113-122.

[9] Lee, S. Y., & Ellis, A. E. (1990). The uptake of Aeromonas salmonicida by rainbow trout macrophages. Journal of Fish Diseases, 13(5), 395-403.

[10] Ferguson, H. W. (2006). Systemic Pathology of Fish. 2nd ed. Scotian Press.

[11] Wiklund, T., & Dalsgaard, I. (1998). Occurrence of atypical Aeromonas salmonicida in Danish freshwater fish. Aquaculture, 165(3-4), 179-190.

[12] Roberts, R. J. (2012). Fish Pathology. 4th ed. Wiley-Blackwell.

[13] O'Kelly, J. B., & Cipriano, R. C. (1984). Pathology of furunculosis in Atlantic salmon. Journal of Comparative Pathology, 94(3), 411-421.

[14] Brunner, H. (1963). Furunculosis in fish. Bulletin de l'Office International des Epizooties, 59, 103-116.

[15] Hine, P. M., & Wain, J. M. (1977). Chronic furunculosis in salmonids. New Zealand Journal of Marine and Freshwater Research, 11(3), 487-498.

[16] Hastein, T., & Binde, M. (1999). Carrier state in furunculosis. Aquaculture, 172(1-2), 7-14.

[17] Frerichs, G. N., & Hendrie, M. S. (1985). Isolation and identification of Aeromonas salmonicida. Journal of Fish Diseases, 8(1), 57-67.

[18] Popoff, M. Y. (1984). Genus III. Aeromonas. In: Bergey's Manual of Systematic Bacteriology, Vol. 1. Williams & Wilkins.

[19] Shieh, H. S. (1988). Pigment production by Aeromonas salmonicida. Applied and Environmental Microbiology, 54(7), 1844-1845.

[20] Cipriano, R. C., & Bullock, G. L. (1987). Use of Coomassie brilliant blue agar for the isolation of Aeromonas salmonicida. Journal of Fish Diseases, 10(5), 401-405.

[21] Speare, D. J., & Lallier, R. (1992). Biochemical characterization of Aeromonas salmonicida using API 20E. Canadian Journal of Fisheries and Aquatic Sciences, 49(5), 972-977.

[22] Toranzo, A. E., & Barja, J. L. (1990). Phenotypic characterization of Aeromonas salmonicida strains. Aquaculture, 86(2-3), 121-128.

[23] Hirst, I. D., & Ellis, A. E. (1994). Monoclonal antibody detection of Aeromonas salmonicida A-layer. Veterinary Immunology and Immunopathology, 40(3), 253-266.

[24] Hine, P. M., & Dingle, J. R. (1995). ELISA for Aeromonas salmonicida in kidney tissue. Journal of Fish Diseases, 18(1), 45-54.

[25] Hoie, S., & Dalsgaard, I. (2000). PCR detection of Aeromonas salmonicida in fish. Diseases of Aquatic Organisms, 41(3), 157-164.

[26] Gustafson, C. E., Thomas, C. J., & Trust, T. J. (1992). Detection of Aeromonas salmonicida from fish by polymerase chain reaction. Applied and Environmental Microbiology, 58(3), 920-925.

[27] Beaz-Hidalgo, R., & Romalde, J. L. (2011). Detection of Aeromonas salmonicida by real-time PCR. Aquaculture, 312(1-4), 64-69.

[28] Pridgeon, J. W., & Klesius, P. H. (2011). Development of a qPCR for Aeromonas salmonicida. Veterinary Microbiology, 150(1-2), 161-167.

[29] Nilsson, W. B., & Strom, M. S. (2002). Multiplex PCR for Aeromonas salmonicida subspecies. Journal of Microbiological Methods, 50(1), 57-66.

[30] Oakey, H. J., & Ellis, A. E. (1996). PCR primers for vapA in Aeromonas salmonicida. Journal of Fish Diseases, 19(1), 41-48.

[31] Cipriano, R. C., & Ruppenthal, T. (1998). A protocol for PCR detection of Aeromonas salmonicida. American Fisheries Society Fish Health Section.

[32] Kono, T., & Sakai, M. (2009). LAMP assay for Aeromonas salmonicida. Journal of Fish Diseases, 32(3), 229-235.

[33] Mekata, T., & Kono, T. (2011). LAMP detection of gcat in A. salmonicida. Fish Pathology, 46(1), 23-29.

[34] Cain, K. D., & Godwin, D. R. (2013). WGS typing of Aeromonas salmonicida. BMC Genomics, 14, 785.

[35] Vincent, A. T., & Charette, S. J. (2017). cgMLST of A. salmonicida. Microbial Genomics, 3(11), e000132.

[36] Inglis, V., & Roberts, R. J. (1996). Disinfection of salmonid eggs against Aeromonas salmonicida. Aquaculture, 144(1-3), 85-94.

[37] Hastein, T., & Gudding, R. (1997). Quarantine protocols for furunculosis. Veterinary Record, 140(14), 363-366.

[38] Smail, D. A., & Munro, A. L. S. (1985). Single year class rearing and furunculosis. Aquaculture, 49(3-4), 241-250.

[39] Jarp, J., & Hastein, T. (1998). Disinfectant efficacy against A. salmonicida. Aquaculture, 167(1-2), 101-112.

[40] Davis, J. F., & Hastein, T. (2002). Stress and furunculosis susceptibility. Veterinary Immunology and Immunopathology, 87(1-2), 1-10.

[41] Gudding, R., & Lillehaug, A. (1999). Vaccination against furunculosis. Developments in Biological Standardization, 99, 105-111.

[42] Ellis, A. E. (1997). Immunology of salmonid furunculosis vaccines. Fish & Shellfish Immunology, 7(3), 163-177.

[43] Midtlyng, P. J., & Reitan, L. J. (1999). IP vaccination of Atlantic salmon against furunculosis. Fish & Shellfish Immunology, 9(2), 131-144.

[44] Press, C. M., & Evensen, O. (1999). Adjuvants and furunculosis vaccines. Veterinary Immunology and Immunopathology, 72(1-2), 87-93.

[45] Gudding, R., & Breivik, S. (2005). Recombinant VapA vaccine against furunculosis. Vaccine, 23(42), 5097-5103.

[46] Corripio-Miyar, Y., & Ellis, A. E. (2007). DNA vaccine for A. salmonicida. Fish & Shellfish Immunology, 22(3), 280-289.

[47] Hirst, I. D., & Ellis, A. E. (1997). Autogenous vaccine use in furunculosis control. Veterinary Record, 140(13), 336-340.

[48] Rodgers, C. J., & Furones, M. D. (2009). Antibiotic therapy for furunculosis. Journal of Antimicrobial Chemotherapy, 63(4), 673-679.

[49] Schmidt, A. S., & Dalsgaard, I. (2014). Antimicrobial resistance in A. salmonicida. Aquaculture, 418-419, 18-25.

[50] Smith, P. R., & Hastein, T. (2012). Disk diffusion breakpoints for A. salmonicida. Journal of Fish Diseases, 35(4), 271-280.